Inogen, an oxygen supply device manufacturer, is notifying 30,000 existing and former customers their personal data may have been improperly accessed, Reuters reports. An unauthorized party may have ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction of ...
Environment Analyst's annual Market Assessment identifies the leading firms in the Global environmental & sustainability (E&S) consulting market by E&S consulting revenue. SAINT PAUL, MN / ACCESS ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the company ...
Developed in collaboration with Yuwell Medical, Voxi 5 presents a viable option for patients seeking reliable stationary oxygen therapy, delivering 1-5 L/min of quiet 1, pure 2, continuous flow oxygen ...
Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (“POC”) space. The optimism, led by solid first-quarter 2025 ...
Inogen ($INGN) is up almost 10% on news that it received FDA clearance for its latest home oxygen concentrator. Later this year, the company expects to start selling ...
Inogen, a California company, plans to open a sales office in the former American Greetings building in Brooklyn. It will bring about 240 jobs to the area. (Courtesy of Inogen) CLEVELAND, Ohio - ...
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of ...
Inogen’s Q1 2023 results disappointed the market, despite management’s confirmation that previously issued FY23E guidance remained unchanged. New product launches, including Rove 6 distribution in ...
Medical Technology company Inogen Inc (NASDAQ:INGN) reported a fourth-quarter adjusted EPS loss of 24 cents, compared to a loss of 83 cents a year ago, beating the consensus loss of 61 cents. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results